NEKTAR THERAPEUTICS's ticker is and the CUSIP is 640268908. A total of 3 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | +50.0% | 6,200 | +29.2% | 0.00% | – |
| Q2 2023 | $2 | 0.0% | 4,800 | +33.3% | 0.00% | – |
| Q1 2023 | $2 | -88.9% | 3,600 | -57.1% | 0.00% | – |
| Q4 2022 | $18 | -100.0% | 8,400 | -96.3% | 0.00% | -100.0% |
| Q3 2022 | $724,000 | -22.3% | 226,400 | -7.8% | 0.00% | 0.0% |
| Q2 2022 | $932,000 | +77.2% | 245,500 | +151.3% | 0.00% | – |
| Q1 2022 | $526,000 | -18.8% | 97,700 | +103.5% | 0.00% | -100.0% |
| Q4 2021 | $648,000 | +217.6% | 48,000 | +310.3% | 0.00% | – |
| Q3 2021 | $204,000 | +7.4% | 11,700 | +5.4% | 0.00% | – |
| Q2 2021 | $190,000 | -67.1% | 11,100 | +3740.8% | 0.00% | -100.0% |
| Q1 2021 | $578,000 | -64.0% | 289 | -69.4% | 0.00% | -50.0% |
| Q4 2020 | $1,604,000 | +206.1% | 944 | +198.7% | 0.00% | +100.0% |
| Q3 2020 | $524,000 | -39.8% | 316 | -16.0% | 0.00% | 0.0% |
| Q2 2020 | $870,000 | +806.2% | 376 | +596.3% | 0.00% | – |
| Q1 2020 | $96,000 | -94.2% | 54 | -93.0% | 0.00% | -100.0% |
| Q4 2019 | $1,666,000 | -32.4% | 772 | -43.0% | 0.00% | -42.9% |
| Q3 2019 | $2,466,000 | +42.1% | 1,354 | +177.5% | 0.01% | +40.0% |
| Q2 2019 | $1,736,000 | +2.1% | 488 | -3.6% | 0.01% | 0.0% |
| Q1 2019 | $1,700,000 | +28.7% | 506 | +25.9% | 0.01% | +25.0% |
| Q4 2018 | $1,321,000 | -14.3% | 402 | +58.9% | 0.00% | -20.0% |
| Q3 2018 | $1,542,000 | -54.4% | 253 | -63.5% | 0.01% | -61.5% |
| Q2 2018 | $3,383,000 | +723.1% | 693 | +497.4% | 0.01% | -27.8% |
| Q1 2018 | $411,000 | -72.5% | 116 | -76.7% | 0.02% | -71.9% |
| Q4 2017 | $1,495,000 | +5239.3% | 498 | +277.3% | 0.06% | +6300.0% |
| Q3 2017 | $28,000 | +27.3% | 132 | -66.7% | 0.00% | 0.0% |
| Q2 2017 | $22,000 | -95.5% | 396 | -38.3% | 0.00% | -95.2% |
| Q1 2017 | $493,000 | +9760.0% | 642 | +817.1% | 0.02% | – |
| Q4 2016 | $5,000 | +25.0% | 70 | +18.6% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 59 | -45.9% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 109 | +505.6% | 0.00% | – |
| Q1 2016 | $2,000 | -98.1% | 18 | -92.4% | 0.00% | -100.0% |
| Q4 2015 | $103,000 | – | 237 | +478.0% | 0.01% | – |
| Q3 2015 | $0 | -100.0% | 41 | -78.8% | 0.00% | -100.0% |
| Q2 2015 | $12,000 | +1100.0% | 193 | +135.4% | 0.00% | – |
| Q1 2015 | $1,000 | -92.3% | 82 | +20.6% | 0.00% | -100.0% |
| Q4 2014 | $13,000 | – | 68 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 36,600 | $139,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 178,700 | $679,000 | 0.00% |
| SIMPLEX TRADING, LLC | 245,500 | $932,000 | 0.00% |
| JANE STREET GROUP, LLC | 160,000 | $608,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |